Deltagen Reports 2014 Full Year Financial Results

SAN MATEO, Calif.--(BUSINESS WIRE)--Deltagen, Inc. (Pink Sheets: DGEN), a provider of drug discovery tools and services to the biopharmaceutical industry, today reported unaudited consolidated financial results for the year ended December 31, 2014.

Revenues: The Company’s consolidated revenues for the year ended December 31, 2014 totaled $0.870 million. The revenues were attributable primarily to license fees associated with the provision of knockout mice and related phenotypic data pursuant to orders placed by customers under the Company’s DeltaOneTM program.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC